|
|
|
|
|
by linuxftw
1971 days ago
|
|
Interesting bits about the 'bottleneck' being the lipid envelope. This sounds highly proprietary and very, very new (eg, not widely tested). How can these products be QA'd by an independent lab to be free from significant defects? Are the doses being distributed produced on the same line with the same procedure as the doses in the trials? |
|
The idea that there are significant side effects that have failed to surface makes zero sense.